These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29301820)

  • 1. Unilateral orbital fat change.
    Yip IYM; Ramasamy B
    BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29301820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periorbital fat atrophy - an unfamiliar side effect of prostaglandin analogues.
    Jayaprakasam A; Ghazi-Nouri S
    Orbit; 2010 Dec; 29(6):357-9. PubMed ID: 21158579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin analogues: A double-edged sword in orbital glaucoma disease management.
    Joganathan V; Cannon PS; Mercieca K
    Eur J Ophthalmol; 2021 May; 31(3):NP40-NP44. PubMed ID: 32043370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unilateral Prostaglandin-Associated Periorbitopathy: A Syndrome Involving Upper Eyelid Retraction Distinguishable From the Aging Sunken Eyelid.
    Rabinowitz MP; Katz LJ; Moster MR; Myers JS; Pro MJ; Spaeth GL; Sharma P; Stefanyszyn MA
    Ophthalmic Plast Reconstr Surg; 2015; 31(5):373-8. PubMed ID: 25393907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shortening of Interpupillary Distance after Instillation of Topical Prostaglandin Analog Eye Drops.
    Sano I; Takahashi H; Inoda S; Sakamoto S; Arai Y; Takahashi Y; Ohkubo A; Kawashima H; Mayama C
    Am J Ophthalmol; 2019 Oct; 206():11-16. PubMed ID: 30902695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost.
    Kucukevcilioglu M; Bayer A; Uysal Y; Altinsoy HI
    Clin Exp Ophthalmol; 2014 Mar; 42(2):126-31. PubMed ID: 23844550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin-Associated Periorbitopathy in Children and Young Adults with Glaucoma.
    Kim JS; Blizzard S; Woodward JA; Leyngold IM; Liss J; Freedman SF
    Ophthalmol Glaucoma; 2020; 3(4):288-294. PubMed ID: 33008561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orbital Fat Volume After Treatment with Topical Prostaglandin Agonists.
    Chen JY; Le A; Caprioli J; Giaconi JA; Nouri-Mahdavi K; Law SK; Bonelli L; Coleman AL; Demer JL
    Invest Ophthalmol Vis Sci; 2020 May; 61(5):46. PubMed ID: 32455434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latanoprost-induced prostaglandin-associated periorbitopathy.
    Tan J; Berke S
    Optom Vis Sci; 2013 Sep; 90(9):e245-7; discussion 1029. PubMed ID: 23912967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clicking Eyelids: A New Finding of Prostaglandin-Associated Periorbitopathy.
    Skorin L; Dailey KH
    Optom Vis Sci; 2016 Jul; 93(7):779-81. PubMed ID: 27055061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpetic keratitis in a patient who used two different prostaglandin analogue ophthalmic solutions: a case report.
    Villegas VM; Díaz L; Izquierdo NJ
    P R Health Sci J; 2008 Dec; 27(4):348-9. PubMed ID: 19069363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Audible blink in prostaglandin-associated periorbitopathy.
    Fong CS; Rajak SN; Pirbhai A; Selva D
    Clin Exp Ophthalmol; 2016 Sep; 44(7):630-631. PubMed ID: 26872687
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on ocular inflammation and development of a prostaglandin analogue for glaucoma treatment.
    Stjernschantz J
    Exp Eye Res; 2004 Apr; 78(4):759-66. PubMed ID: 15037110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of Prostaglandin-Associated Periorbitopathy after Discontinuing Treatment.
    Abalo-Lojo JM; Ferreiro PV; Asorey MK; Colmenero AE; Gonzalez F
    Turk J Ophthalmol; 2023 Feb; 53(1):8-12. PubMed ID: 36847619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostaglandin-associated periorbitopathy].
    Zhang F; Liao S; Liu K; Duan XC
    Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):637-640. PubMed ID: 28851204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Orbital fat atrophy in glaucoma patients treated with topical bimatoprost--can bimatoprost cause enophthalmos?].
    Tappeiner C; Perren B; Iliev ME; Frueh BE; Goldblum D
    Klin Monbl Augenheilkd; 2008 May; 225(5):443-5. PubMed ID: 18454393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Initial medical treatment: beta-blockers or prostaglandins. Prostaglandins: a modern glaucoma treatment].
    Baudouin C
    J Fr Ophtalmol; 2004 Jun; 27(6 Pt 2):718-9. PubMed ID: 15319756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between topical prostaglandin analog use and development of choroidal neovascular membranes in patients with concurrent glaucoma and age-related macular degeneration.
    Scherer WJ
    J Ocul Pharmacol Ther; 2006 Apr; 22(2):139-44. PubMed ID: 16722800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin associated periorbitopathy.
    Abalo-Lojo JM; Gonzalez F
    Arch Soc Esp Oftalmol; 2016 May; 91(5):207-8. PubMed ID: 26810906
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between glaucoma eye drops and hyperemia.
    Yanagi M; Kiuchi Y; Yuasa Y; Yoneda T; Sumi T; Hoshikawa Y; Kobayashi M; Fukushima A
    Jpn J Ophthalmol; 2016 Mar; 60(2):72-7. PubMed ID: 26847553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.